Social Anxiety Disorder in Medical Students in Sohag University (SAD-Med-Soh)

November 16, 2024 updated by: Mina Saad Louis, Sohag University
The study will be done in Sohag University to assess the prevalence and associated factors of Social Anxiety Disorder among undergraduate medical students .

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Social anxiety disorder (SAD) is highly prevalent and it's the most common anxiety disorder among all types of anxiety disorders and the third most common psychiatric condition after major depression and alcohol dependence.

Social anxiety disorder (SAD) is characterized by persistent fear/anxiety about one or more social or performance situations in social settings.

SAD had a negative impact on learning ability, educational achievement, professional achievement, quality of life and social relationship & may lead to substance abuse and depressive disorders.

Study Type

Observational

Enrollment (Actual)

360

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

The study will be conducted among medical undergraduate students in Sohag University.

Description

Inclusion Criteria:

  • Medical undergraduate students who are still studying for Bachelor of Medicine and Bachelor of Surgery ( M.B.B.Ch ) .

Exclusion Criteria:

  • students who will refuse to participate in this study .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Phobia Inventory ( SPIN ) questionnaire
Time Frame: It will be measured after completion of the study , approximately in May 2023.

Social Phobia Inventory ( SPIN ) questionnaire which is consisted of 17 items. The answers of each item ranged from 0 ( Not at all ) to 4 ( Extremely ).

The total score will be calculated to determine the severity of the problem as the following: - less than or equal 20 points means no disease, 21-30 means mild, 31-40 means moderate, 41-50 means severe , 51 or more means very severe.
It will be measured after completion of the study , approximately in May 2023.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Investigators

  • Study Director: Osama Morad, Lecturer, osama_morad@med.sohag.edu.eg
  • Study Director: Taher Abd-Elraheem-Sayed, Assistant professor, Dr_taher65@yahoo.com

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2022

Primary Completion (Actual)

November 16, 2024

Study Completion (Actual)

November 16, 2024

Study Registration Dates

First Submitted

April 13, 2022

First Submitted That Met QC Criteria

April 13, 2022

First Posted (Actual)

April 20, 2022

Study Record Updates

Last Update Posted (Estimated)

November 19, 2024

Last Update Submitted That Met QC Criteria

November 16, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med-22-04-13

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Anxiety Disorder

Clinical Trials on Validated questionnaire : Social Phobia Inventory ( SPIN ) questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe